Description
Non-Hormonal Lean Muscle Builder | Blackstone Labs Epi Smash
If you're looking for a non-hormonal was to build lean Muscle, Blackstone Labs has got you covered. Blackstone Labs Epi Smash was formulated to help you build more lean Muscle mass & deliver you with hard & dry gains!! Blackstone Labs Epi Smash delivers Cyclosome Technology for advanced absorption & is 100% non-Hormonal. Epi Smash is a great option for those who want to build lean Muscle, but Hormone-free. On top of all of that, Epi Smash will help to reduce overall Cortisol levels & stress levels. Level up your fitness routine today. Pick up a bottle. Introducing Blackstone Labs Epi Smash!!
Blackstone Labs Epi Smash Benefits
- Helps To Build Lean Muscle Mass
- Easy On-The-Go Capsule Formula
- Supports Completely Hard & Dry Gains
- Delivers Excellent Cyclosome Technology
- 100% Non-Hormonal Supplement
- Helps To Reduce Overall Cortisol & Stress Levels
- Highly Anabolic & Andrigenic Agent
How Do I Take Blackstone Labs Epi Smash?
Blackstone Labs recommends taking one (1) capsule per day with a meal. Men can take 1-3 capsules per day with a meal.
Blackstone Labs Epi Smash Ingredients
Blackstone Labs Epi Smash Side Effects & Warnings
Not for use by individuals under the age of 18 years. Do not take without first consulting with a licensed healthcare provider or physician. Do not take this product if you have been diagnosed with androgen-sensitive cancers, high cholesterol, hypertension, or any other current or pre-existing medical condition. Do not take if pregnant or nursing. Keep out of reach of children.
References
Lakshmi T, Ezhilarasan D, Vijayaragavan R, Bhullar SK, Rajendran R. Acacia catechu ethanolic bark extract induces apoptosis in human oral squamous carcinoma cells. J Adv Pharm Technol Res. 2017;8(4):143-149. doi:10.4103/japtr.JAPTR_73_17
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680622/
Lakshmi T, Ezhilarasan D, Nagaich U, Vijayaragavan R. Acacia catechu Ethanolic Seed Extract Triggers Apoptosis of SCC-25 Cells. Pharmacogn Mag. 2017;13(Suppl 3):S405-S411. doi:10.4103/pm.pm_458_16
